{"acquired gene mutation": 866.34, "alanine aminotransferase increased": 4.11, "aspartate aminotransferase increased": 3.25, "dermatitis acneiform": 51.23, "diarrhoea": 2.46, "disease progression": 9.0, "drug interaction": 4.02, "drug resistance": 157.76, "drug-induced liver injury": 12.82, "egfr gene mutation": 2178.58, "gene mutation": 58.59, "hepatic function abnormal": 12.57, "hepatotoxicity": 17.51, "interstitial lung disease": 19.63, "liver function test abnormal": 7.42, "liver injury": 12.25, "lung adenocarcinoma": 47.02, "lung adenocarcinoma stage iv": 394.9, "malignant neoplasm progression": 37.12, "malignant transformation": 1672.36, "metastases to bone": 31.31, "metastases to central nervous system": 106.91, "metastases to liver": 20.13, "metastases to lung": 30.53, "metastases to lymph nodes": 19.73, "metastases to meninges": 264.01, "myelosuppression": 3.08, "pancreatitis acute": 5.53, "paronychia": 72.17, "pleural effusion": 5.14, "rash": 3.56, "rash pruritic": 3.14, "rash pustular": 25.22, "respiratory failure": 3.64, "skin toxicity": 35.77, "small cell lung cancer": 238.27, "transaminases increased": 6.51}